The Bern Perioperative Biobank
- Conditions
- AnesthesiaSurgical Procedure, Operative
- Registration Number
- NCT04767685
- Lead Sponsor
- Insel Gruppe AG, University Hospital Bern
- Brief Summary
The goal of the research is to define clinically relevant molecular markers for increased risk of peri-/ postoperative organo-dysfunctions, inflammation, adverse events and disease progression. To better understand the perioperative impact the investigators aim to determine perioperative levels of molecular markers over time in the available samples and clinical data of the Bern perioperative Biobank (BPBB) cohort to finally increase quality of perioperative care of patients by permitting preventive measures to be taken early in patients at risk.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 547
- 18 years and older
- Written informed consent
- Non-emergency surgery
Exclusion Criteria
- Transient incapacity to consent or insufficient time (< 6h) to consider study participation
- No informed consent
- Cognitive impairment/Patients unable to consent
- Patients who retrospectively expressed their wish to be excluded
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Assessing the change of the metabolic profile in the perioperative setting On postoperative day 1 during the morning round between 07:30-9:00am Surgery causes significant disruption of physiologic metabolism. The investigators currently lack specific markers to assess change of the metabolic profile in the perioperative setting. The investigators aim to identify metabolic markers and their change in the perioperative period in association with patients' clinical outcome.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Department of Anaesthesiology and Pain Medicine, Inselspital, University of Bern
🇨🇭Bern, Switzerland